A Phase 2a Study
  • Description A forum to discuss or ask questions about a Phase 2a Study to Evaluate the Effect of Rilapladib (SB-659032) on Biomarkers Related to the Pathogenesis and Progression of Alzheimer's Disease
  • Threads 1 Discussion
Frequently Asked